BR0307235A - Composição para inalação - Google Patents

Composição para inalação

Info

Publication number
BR0307235A
BR0307235A BR0307235-5A BR0307235A BR0307235A BR 0307235 A BR0307235 A BR 0307235A BR 0307235 A BR0307235 A BR 0307235A BR 0307235 A BR0307235 A BR 0307235A
Authority
BR
Brazil
Prior art keywords
hfa
inhalation composition
composition
inhalation
copd
Prior art date
Application number
BR0307235-5A
Other languages
English (en)
Inventor
Steve Burns
Philip Wikeley
Original Assignee
Atrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE0200412A external-priority patent/SE0200412D0/xx
Priority claimed from SE0202138A external-priority patent/SE0202138D0/xx
Application filed by Atrazeneca Ab filed Critical Atrazeneca Ab
Publication of BR0307235A publication Critical patent/BR0307235A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics

Abstract

"COMPOSIçãO PARA INALAçãO". A presente invenção se refere a uma nova composição farmacêutica, de utilidade no tratamento de distúrbios respiratórios, tais como, asma, rinite e doença pulmonar obstrutiva crónica (COPD). A composição compreende formoterol, HFA 227, HFA 134a, polivinilpirrolidona (PVP) e polietilenoglicol (PEG).
BR0307235-5A 2002-02-01 2003-01-29 Composição para inalação BR0307235A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE0200412A SE0200412D0 (sv) 2002-02-01 2002-02-01 Novel composition
SE0202138A SE0202138D0 (sv) 2002-07-05 2002-07-05 Novel Composition
PCT/SE2003/000157 WO2003063843A1 (en) 2002-02-01 2003-01-29 Composition for inhalation

Publications (1)

Publication Number Publication Date
BR0307235A true BR0307235A (pt) 2004-12-07

Family

ID=27667648

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0307235-5A BR0307235A (pt) 2002-02-01 2003-01-29 Composição para inalação

Country Status (10)

Country Link
US (1) US20050118107A1 (pt)
EP (1) EP1474118A1 (pt)
JP (1) JP2005530686A (pt)
KR (1) KR20040081753A (pt)
CN (1) CN1622802A (pt)
BR (1) BR0307235A (pt)
CA (1) CA2474690A1 (pt)
MX (1) MXPA04007294A (pt)
NO (1) NO20043489L (pt)
WO (1) WO2003063843A1 (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2005259523B2 (en) * 2004-07-02 2011-06-09 Boehringer Ingelheim International Gmbh Aerosol suspension formulations containing TG 227 ea or TG 134 a as a propellant
DE102006017320A1 (de) * 2006-04-11 2007-10-18 Boehringer Ingelheim Pharma Gmbh & Co. Kg Aerosolsuspensionsformulierungen mit TG 227 ea oder TG 134 a als Treibmittel
WO2008152398A2 (en) * 2007-06-14 2008-12-18 Cipla Limited Formulations for inhalation
GB0712454D0 (en) 2007-06-27 2007-08-08 Generics Uk Ltd Pharmaceutical compositions
US20160310410A1 (en) 2015-04-24 2016-10-27 Glenmark Specialty S.A. Pharmaceutical compositions comprising arformoterol and glycopyrronium
CN106581010B (zh) * 2016-12-28 2019-03-05 四川普锐特医药科技有限责任公司 一种气溶胶制剂及定量吸入气雾剂
CN109464429B (zh) * 2018-12-13 2021-04-27 上海方予健康医药科技有限公司 一种吸入压力定量气雾剂药物组合物及其制备方法
CN110840864B (zh) * 2019-12-20 2022-02-22 广州健康元呼吸药物工程技术有限公司 一种β2受体激动剂吸入气雾剂及包含该吸入气雾剂的产品

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6123924A (en) * 1991-09-25 2000-09-26 Fisons Plc Pressurized aerosol inhalation compositions
CA2271004C (en) * 1996-11-11 2007-05-01 Sepracor Inc. Process for the preparation of optically pure isomers of formoterol
SE9704644D0 (sv) * 1997-12-12 1997-12-12 Astra Ab New use
GB0016876D0 (en) * 2000-07-11 2000-08-30 Astrazeneca Ab Novel formulation

Also Published As

Publication number Publication date
MXPA04007294A (es) 2004-10-29
KR20040081753A (ko) 2004-09-22
EP1474118A1 (en) 2004-11-10
JP2005530686A (ja) 2005-10-13
WO2003063843A1 (en) 2003-08-07
CA2474690A1 (en) 2003-08-07
CN1622802A (zh) 2005-06-01
NO20043489L (no) 2004-08-20
US20050118107A1 (en) 2005-06-02

Similar Documents

Publication Publication Date Title
DK1462100T3 (da) Præparat, der omfatter formoterol og et glucocorticosteroid
UY26959A1 (es) Nuevos polvos para inhalación que contienen tiotropio
IL163160A (en) Pharmaceuticals containing Formavertrol, Budsunida, 227hf 'pvp and peg for the treatment or relief of respiratory disorders
CY1107498T1 (el) Φαρμακευτικη συνθεση πepιλαμβανουσα ρεσβepατρολη για την αγωγη φλεγμονωδων αναπνευστικων διαταραχων
BR0008276A (pt) Combinações de formoterol e propionato de fluticasona para asma
NO20025220D0 (no) Ny fremgangsmÕte
DK1267866T3 (da) Behandling af respirationssygdomme
BRPI0414425A (pt) composições farmacêuticas
BR0307235A (pt) Composição para inalação
ECSP088287A (es) Una combinación de compuestos que puede ser utilizada en el tratamiento de enfermedades respiratorias, especialmente enfermedad pulmonar obstructiva crónica (epoc) y asma
ECSP055821A (es) Nueva formulacion pulverulenta que contiene tiotropio destinado a la inhalación
SE9900833D0 (sv) Novel combination
SG149876A1 (en) Novel tiotropium salts, methods for the production thereof, and pharmaceutical formulations containing the same
SG137859A1 (en) Method for producing tiotropium salts, tiotropium salts and pharmaceutical formulations, containing the same
SE9900834D0 (sv) Novel combination
WO2007046113A3 (en) Novel pharmaceutical composition comprising alkaloid and process thereof

Legal Events

Date Code Title Description
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]